Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Apr 15;199(8):1041-1042.
doi: 10.1164/rccm.201811-2208LE.

Reply to Lescoat et al. and to Khamis et al

Ayodeji Adegunsoye  1 , Justin M Oldham  2 , Anne I Sperling  1 , Imre Noth  3 , Mary E Strek  1 , Jonathan H Chung  1
Affiliations
Comment

Reply to Lescoat et al. and to Khamis et al

Ayodeji Adegunsoye et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Box plots depicting IL-6 (pg/ml) levels stratified by MLN size (mm) in patients with ILD within the UCHICAGO (n = 116) and UCDAVIS (n = 118) cohorts. Comparison of cytokine concentrations in patients with MLN < 10 mm and MLN ≥ 10 mm, using the Wilcoxon signed-rank test for matched nonparametric data in 10,000 bootstrap replications to improve precision at the 95% confidence interval level. (B) Box plots depicting NT-proBNP (pg/ml) levels stratified by MLN size (mm) in patients with ILD within the UCHICAGO cohort (n = 628). For clarity, NT-proBNP data points for two subjects (16,116 and 22,812 pg/ml) are not depicted. Group comparisons for unmatched nonparametric data were conducted using the Pearson chi-squared test for equality of the medians between patients with MLN ≥ 10 mm (purple) and MLN < 10 mm (gray). ILD = interstitial lung disease; MLN = mediastinal lymph node; NTpro-BNP = N-terminal pro–B-type natriuretic peptide; UCDAVIS = University of California, Davis; UCHICAGO = University of Chicago.
See this image and copyright information in PMC

Comment on

References

    1. Adegunsoye A, Oldham JM, Bonham C, Hrusch C, Nolan P, Klejch W, et al. Prognosticating outcomes in interstitial lung disease by mediastinal lymph node assessment: an observational cohort study with independent validation. Am J Respir Crit Care Med. [online ahead of print] 14 Sep 2018; DOI: 10.1164/rccm.201804-0761OC. - PMC - PubMed
    1. Kobayashi T, Tanaka K, Fujita T, Umezawa H, Amano H, Yoshioka K, et al. Bidirectional role of IL-6 signal in pathogenesis of lung fibrosis. Respir Res. 2015;16:99. - PMC - PubMed
    1. Khanna D, Denton CP, Jahreis A, van Laar JM, Frech TM, Anderson ME, et al. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Lancet. 2016;387:2630–2640. - PubMed
    1. Dalleywater W, Powell HA, Hubbard RB, Navaratnam V. Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study. Chest. 2015;147:150–156. - PubMed
    1. Ngom A, Dumont P, Diot P, Lemarié E. Benign mediastinal lymphadenopathy in congestive heart failure. Chest. 2001;119:653–656. - PubMed